Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

A new monthly weight loss drug, MariTide, helped people shed up to 20% of body weight in a Phase 2 trial—comparable to Wegovy ...

Thousand Oaks, California Wednesday, June 25, 2025, 13:00 Hrs [IST] ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

The Federal Motor Carrier Safety Administration (FMCSA) is intensifying enforcement of English Language Proficiency (ELP) ...